COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

BIOmarkers in Severe AsthMa Patients on Omalizumab Treatment (BIOSAMOT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03361111
Recruitment Status : Completed
First Posted : December 4, 2017
Last Update Posted : October 11, 2019
Information provided by (Responsible Party):
Joanna Hermanowicz-Salamon, Medical University of Warsaw

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 5, 2018
Actual Study Completion Date : December 30, 2018